ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc.（NDRA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NDRA · 截至 2026年6月9日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
ENDRA Life Sciences Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
NDRA 季度内部人买卖趋势
NDRA 内幕交易卖出 · NDRA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · NDRA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NDRA 高管卖出股份 · NDRA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 2, 2026 | Tokman Alexander Y CEO · Director | Award | 26,921 | — | Form 4 |
| Mar 2, 2026 | Jacroux Richard CFO | Award | 13,461 | — | Form 4 |
| Jan 21, 2026 | DIGIANDOMENICO ANTHONY Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Harsh Michael Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Jacroux Richard CFO | Award | 20,000 | — | Form 4 |
| Jan 21, 2026 | Basenese Lou Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Tokman Alexander Y CEO · Director | Award | 75,000 | — | Form 4 |
| Oct 10, 2025 | DIGIANDOMENICO ANTHONY Director | Award | 70,822 | $500K | Form 4 |
| Jun 11, 2025 | Basenese Lou Director | Award | 5,384 | — | Form 4 |
| Jun 11, 2025 | Harsh Michael Director | Award | 5,384 | — | Form 4 |
| Jun 11, 2025 | DIGIANDOMENICO ANTHONY Director | Award | 5,384 | — | Form 4 |
| Aug 27, 2024 | UBS Group AG 10 percent owner | Purchase | 3,715 | $2K | Form 4 |
| May 18, 2023 | Thornton Michael Milos CTO | Purchase | 15,000 | $25K | Form 4 |
| May 2, 2023 | DIGIANDOMENICO ANTHONY Director | Purchase | 83,333 | $100K | Form 4 |
| Dec 9, 2022 | Thornton Michael Milos CTO | Purchase | 1,500 | $5K | Form 4 |
| Nov 23, 2022 | Tokman Alexander Y Director | Purchase | 10,000 | $2K | Form 4 |
| Aug 22, 2022 | Thornton Michael Milos CTO | Purchase | 20,000 | $5K | Form 4 |
| Aug 22, 2022 | Tokman Alexander Y Director | Purchase | 20,000 | $5K | Form 4 |
| May 26, 2022 | Thornton Michael Milos CTO | Purchase | 25,000 | $5K | Form 4 |
| May 18, 2022 | Thornton Michael Milos CTO | Purchase | 25,000 | $6K | Form 4 |
| May 17, 2022 | Michelon Francois Roger CEO | Purchase | 5,100 | $969 | Form 4 |
| May 16, 2022 | Tokman Alexander Y Director | Purchase | 100,000 | $20K | Form 4 |
| Jan 28, 2021 | Thornton Michael Milos CTO | Award | 22,815 | — | Form 4 |
| Aug 25, 2021 | Basenese Lou Director | Sale | 45,000 | $82K | Form 4 |
| Aug 26, 2021 | Basenese Lou Director | Sale | 5,000 | $9K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NDRA 内幕交易
NDRA 内幕交易
ENDRA Life Sciences Inc.（NDRA）内幕交易数据来源于公司内部人（包括DIGIANDOMENICO ANTHONY (Director), Tokman Alexander Y (CEO · Director), Jacroux Richard (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。NDRA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ENDRA Life Sciences Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NDRA 内幕交易 · 5个问题ENDRA Life Sciences Inc.（NDRA）的内部人包括高管和董事，如DIGIANDOMENICO ANTHONY (Director), Tokman Alexander Y (CEO · Director), Jacroux Richard (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026